Harmonizing research outcomes for polycystic ovary syndrome (HARP), a marathon not a sprint: current challenges and future research need [PDF]
, 2020 Bassel H. Al Wattar +18 more
openalex +1 more source
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome [PDF]
, 2004 The aim of this study was to evaluate the presence of early vascular damage in young normal-weight women with polycystic ovary syndrome (PCOS).Thirty young normal-weight women with PCOS, who had no additional metabolic or cardiovascular diseases, and 30 ...
B. De Simone +9 more
core +1 more source
Health-related Quality of Life in Women with Polycystic Ovary Syndrome
Medisur, 2014 Polycystic ovary syndrome is the most frequent endocrine and metabolic disorder in women of reproductive age. Its characteristic signs and symptoms are menstrual irregularities, amenorrhea, acne, hirsutism, obesity and infertility.
Belén Carazo Hernández +5 more
doaj +2 more sources
Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
Бюллетень сибирской медицины, 2018 Aim. Polycystic ovary syndrome is a common cause of infertility. In addition, polycystic ovary syndrome is often associated with metabolic complications. In most women hyperandrogenic manifestations occur during puberty.
E. M. Bogatyreva, G. A. Novik
doaj +1 more source
Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome [PDF]
, 2016 © 2016 John Wiley & Sons Ltd Context: Animal studies suggest that cannabinoid receptor-1 (CB-1) blockade reduces inflammation and neovascularization by decreasing vascular endothelial growth factor (VEGF) levels associated with a reduction in ...
Atkin, Stephen L. +4 more
core +1 more source
Women's HealthPolycystic ovary syndrome is a common reproductive endocrine condition that affects women of fertile age and is characterized by three main features, including hyperandrogenism, chronic anovulation, and polycystic ovaries. In addition, half of women with
Salwa Bader +3 more
doaj +1 more source
Balkan Medical Journal, 2018 Background: Polycystic ovary syndrome is the most frequently seen endocrine disorder in women of reproductive age with a prevalence of about 10%. Aims: To investigate the efficiency of growth differentiation factor 9 and bone morphogenetic protein 15 ...
Meryem İlkay Karagül1 +4 more
doaj +1 more source
Salivary testosterone measurement in women with and without polycystic ovary syndrome [PDF]
, 2017 Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65
Adaway, Joanne +9 more
core +1 more source
SAGE Open MedicineObjectives: The purpose of this scoping review is to explore research studies on the association between chronic pain and polycystic ovary syndrome to create local (U.S.-based) and global recommendations to improve access to and quality of affordable ...
Lea Sacca +7 more
doaj +1 more source
Symptoms of anxiety and depression and health-related quality of life in women with severe obesity and polycystic ovary syndrome and the effect of a one year weight loss intervention [PDF]
, 2023 Josefin Kataoka +6 more
openalex +1 more source